Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 755.90

+2.6%

Nov 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (2158)	8/3/2017 9:43:30 AM
From: Miljenko Zuanic	Read Replies (1) of 3559

<It appears that Eylea will do well in 2Q...> $919 M is even bit better than I expected,...lucentis is in trouble. Regards the dupi Rx and sale for 2H-2017, REGN have no idea what it may be....none has! Long term clue will be in new trials results.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next